Why Trump Has Rejected Big Pharma Contributions Since 2016

“I don’t want their money,” President Donald J. Trump announced at an Atlanta drug addiction event in 2019. “They have got to do what is right.”

Trump’s announcement against Big Pharma brought shockwaves throughout the halls of Congress, the Senate and Deep State Capitol Hill.

He was actually rejecting campaign contributions from the powerful pharmaceutical industry, calling them out for their role in the national opioid addiction epidemic.

Trump’s administration continued with their scrutiny of pharmaceutical companies–despite mainstream media and Democratic counter attacks–as part of his initiative to combat addiction to prescription painkillers.

The week before Trump’s declaration, Federal prosecutors charged opioid distributor Rochester Drug Cooperative and its former chief executive with felonies — the first case of its kind related to the opioid crisis.

“We are holding big pharma accountable,” Trump said.

Dr. Anthony Fauci was visibly upset. He went into high gear with phone calls, emails and personal meetings with Deep State operatives, key Democrats and his China connections.

Within a year the world experienced a pandemic. Unknown to Trump at the time, the tentacles of Big Pharma reached into the highest levels of government, including Vice President Mike Pence and his staff.

Fast forward to 2021, when there were only three FDA-authorized companies authorized to distribute the extremely controversial experimental COVID vaccines in the United States. That’s not all they had in common. Each had former FDA Commissioners in their higher ranks.

The Freedom First Network were early to report the shameful drug industry habit in America.

Johnson & Johnson, Pfizer, and the company that founded Moderna, have each rostered a series of former top ranking government officials into key high level positions in their respective organizations.

In plain words, they bought themselves former FDA commissioners.

Among the top ten stocks owned by U.S. Congress members are Pfizer, Johnson & Johnson and Moderna.

Pfizer

Former FDA Commissioner Scott Gottlieb, sits on the board of Pfizer.


A frequent Pfizer-sponsored CNBC guest, Gottlieb maintains several thousand shares of Pfizer stock, and is compensated well into the six figures on an annual basis.


Gottlieb earns millions from his continually increasing board appointments to an overabundance of pharmaceutical and healthcare companies.


The pandemic profiteer also sits on the boards of Illumina and Tempus Labs, which sell FDA-authorized COVID-19 test kits.


Additionally, Gottlieb sits on the board of Aetion, which has partnered with the FDA on researching COVID-19 policy.

Moderna

Stephen Hahn actually led the FDA when it authorized Moderna’s COVID shots.


He soon took an executive level position with Flagship Pioneering, the company that launched Moderna.


Flagship held 20 million shares of Moderna stock, which in October 16, 2021, was valued at $6.5 Billion.


They earned $1.4 billion through the sale of Moderna stock earlier that year.

Johnson & Johnson

Mark McClellan was the FDA commissioner from 2002-2004 (and served in other high-ranking government posts).


He maintained a board of directors seat with pharma giant Johnson & Johnson since 2013.


McClellan owns thousands of shares in the company and receives around $300,000 annually.

This practice is common in government, politics, lobbyists, and influential business peddlers country wide–from municipal to federal levels–but the use of public-sector private-sector revolving door system is an addiction of corruption.

Dishonest Standard

Basically, this dishonest standard imposes their will on the American public and creates wealth for executives, shareholders, and politicians in the process.

Whether it be former Dominion employees working for the EAC, former Hedge fund managers working for the SEC, former generals working for the military complex, or former FDA Commissioners working for Big Pharma, the conflicts of interest are alarming.

After the Obama Administration left D.C., the Center for Public Integrity and other investigative organizations discovered that the companies producing drugs like Percocet, Vicodin and OxyContin collectively handed more than $900 million over to senators and representatives in every single state, as a means by which to ensure new measures restricting distribution of an access to opioids would not come into force.

Reports indicated this is about 800% more than the amount spent by gun lobbyists.

This practice of movement between the government and big business is dangerous due to the conflicts of interest that arise and why the Department of Government Efficiency (DOGE) has moved into action.

☆☆☆☆☆

IN GOD WE TRUST

Thanks for supporting independent true journalism with a small tip. Dodie & Jack


Dodie & Jack Dennis are regular customers of Green Pasture. Highly recommended.


Green Pasture Here!

Code: CLEVER10

Use Code CLEVER10 for a 10% discount on other Green Pasture products today!

CLICK HERE for GOOD HEALTH!

GREENPASTURE.ORG

Get Your Natural Vitamins A & D from the Sea!

WWW.GRIEFSHARE.ORG

☆☆☆☆☆

New book by award-winning Texas author Cynthia Leal Massey out August 1, 2021.

See details here!

5 comments

  1. Love the lightning shot striking the Capitol. If I don’t miss my guess, the hand wielding that lightning belongs to the one who is really orchestrating the cleanup of this many tentacled creature we refer to as “The Swamp.” Big Pharma sounds like it might have its own separate acreage in it: Huge.

    Liked by 2 people

Leave a reply to Texans Jack & Dodie Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.